verified_user
Standardful
首頁chevron_right標準chevron_rightGMP(cGMP)
現行有效國際標準update 最後更新:持續更新

GMP(cGMP)

藥品生產品質管理規範——WHO 指南與 FDA 21 CFR 210/211

apartment發布組織:世界衛生組織(WHO)/ 美國食品藥物管理局(FDA)

標準簡介

良好生產規範(GMP,或稱 cGMP「現行良好生產規範」)是一套確保藥品、食品、生物製品和醫療器材按照品質標準持續生產和控制的指導方針體系。世界衛生組織於 1969 年首次發布 GMP 指南,超過 100 個國家已將 WHO GMP 條款納入其國家法律。在美國,FDA 透過 21 CFR 第 210 和 211 部分執行 cGMP 法規。

GMP 涵蓋生產的各個面向——從人員資格和設施設計到原物料控制、製程驗證、品質控制檢測和配銷。其原則要求製造商記錄和驗證生產的每個步驟,維護清潔和受控的設施,使用經過確認的設備,並保存完整的紀錄。全球監管機構透過稽核來驗證合規性,違規行為可能導致警告信、產品回收、工廠關閉和刑事訴追。

science

Quality Assurance Framework

Ensures pharmaceutical and food products are consistently produced and controlled according to quality standards appropriate to their intended use.

public

Global Regulatory Foundation

Over 100 countries have incorporated WHO GMP provisions into their national medicines laws. The FDA enforces cGMP through 21 CFR Parts 210 and 211.

verified

Production & Control Standards

Covers personnel qualification, facility design, equipment validation, raw material controls, production processes, quality control testing, and documentation.

list_alt Core GMP Principles

  • Personnel qualification, training, and hygiene
  • Premises and equipment design and maintenance
  • Documentation and record keeping
  • Production process validation and control
  • Quality control and laboratory testing
  • Complaint handling and product recalls
  • Self-inspection and quality audits
  • Sanitation and contamination prevention

Who Needs to Comply?

groups

Manufacturers of pharmaceutical products, active pharmaceutical ingredients (APIs), biologicals, vaccines, medical devices, food products, and cosmetics. Required by virtually every national regulatory authority worldwide.

Key Requirements

1

Quality Management System

Establish a comprehensive quality management system covering production and quality control, with a designated quality unit independent of production responsible for release of finished products.

2

Process Validation

Validate manufacturing processes to demonstrate they consistently produce product meeting predetermined specifications and quality attributes. Maintain ongoing process verification.

3

Documentation & Records

Maintain complete batch production records, equipment logs, laboratory records, and standard operating procedures. All records must be contemporaneous, attributable, and indelible.

4

Facility & Equipment Controls

Design and maintain facilities and equipment to prevent contamination, mix-ups, and errors. Implement qualification protocols (IQ/OQ/PQ) for critical equipment.

5

Quality Control Testing

Operate adequately equipped laboratories with trained personnel to test raw materials, intermediates, and finished products against established specifications before release.

Penalties & Enforcement

warning

FDA penalties include warning letters, product seizures, injunctions, facility shutdowns, consent decrees, and criminal prosecution. Adulterated drugs under 21 USC 331 can result in fines up to $500,000 and imprisonment up to 3 years. WHO prequalification loss bars products from UN procurement.

官方文件

查看全部

實施時間線

gavel
1962年
US Congress mandates FDA to require GMP for drugs (Kefauver-Harris Amendment)
public
1969年
WHO publishes first GMP guidelines as part of Certification Scheme
description
1978年
FDA finalizes 21 CFR Parts 210 and 211 (cGMP for finished pharmaceuticals)
science
2000年
ICH Q7 GMP guide for Active Pharmaceutical Ingredients published
update
2014年
WHO TRS 986 Annex 2 updated GMP guidelines published
new_releases
2025年
FDA issues updated guidance on pharmaceutical CGMP practices

相關分類